Viral pneumonia is a lung infection caused by a virus that inflames the tiny air sacs (alveoli) where oxygen normally passes into your bloodstream. It accounts for a significant share of pneumonia cases and can range from mild enough to treat at home to severe enough to require hospitalization. Unlike bacterial pneumonia, viral pneumonia typically comes on gradually, produces a dry cough rather than one full of colored mucus, and often follows a respiratory illness like the flu or a bad cold.
How Viruses Damage the Lungs
A virus can reach your lungs in a few different ways. Most commonly, you inhale viral particles directly into the lower airways, which is how influenza and RSV cause pneumonia. Sometimes a virus that started as an upper respiratory infection spreads downward into the lungs. In rarer cases, a virus traveling through the bloodstream from another part of the body settles in lung tissue.
Once a virus reaches the alveoli, it attacks the cells lining those air sacs. The immune system responds by flooding the area with white blood cells and inflammatory signals, which causes the walls of the alveoli to swell and leak fluid. That fluid buildup is what makes breathing difficult. In mild cases, the swelling resolves as the immune system clears the virus. In severe cases, the inflammation can become so widespread that fluid fills the air sacs entirely, a condition known as acute respiratory distress syndrome (ARDS), which can be life-threatening.
Which Viruses Cause It
The CDC lists six viruses that commonly cause pneumonia: COVID-19, influenza, respiratory syncytial virus (RSV), human metapneumovirus (HMPV), human parainfluenza virus, and rhinovirus. Influenza and RSV have been major causes for decades, while COVID-19 became a leading cause starting in 2020. RSV is especially dangerous for young children. A 2005 global study found RSV was responsible for 22% of acute lower respiratory infections in children under 5, leading to roughly 3.4 million hospitalizations and 66,000 to 199,000 deaths worldwide, with 99% of those deaths in developing countries.
Who Is Most at Risk
The burden of viral pneumonia falls hardest on two age groups: children under 5 and adults over 50. Among children hospitalized for community-acquired pneumonia in a large U.S. study (the CDC’s EPIC study), 70% were under 5 years old. Hospitalization rates were highest in children under 2, at about 62 per 10,000 children per year, dropping to roughly 24 per 10,000 for children aged 2 to 4. Globally, pneumonia kills an estimated 900,000 children under 5 every year.
In adults, the overall hospitalization rate for community-acquired pneumonia was about 25 per 10,000, and the rate climbed steadily with age, peaking in those 50 and older. People with chronic medical conditions like diabetes, heart disease, or lung disease face higher risk at any age, as do people with weakened immune systems.
Symptoms and How They Differ From Bacterial Pneumonia
Viral pneumonia symptoms usually develop over several days rather than hitting all at once. The hallmark is a dry cough, often accompanied by fever, body aches, fatigue, and shortness of breath. You might feel like you have a worsening cold or flu that has “moved into your chest.”
Bacterial pneumonia, by contrast, can strike suddenly with a high fever (up to 105°F), shaking chills, and a cough that produces yellow, green, or bloody mucus. Viral pneumonia tends to feel more like a slow burn. That said, the two types can look similar enough that doctors often need tests to tell them apart, and it’s possible to have both at the same time.
How It’s Diagnosed
Doctors typically start with a physical exam and a chest X-ray. Viral pneumonia often shows hazy, ground-glass patches spread across both lungs on imaging, while bacterial pneumonia more commonly appears as a dense white area in one section of one lung. The imaging patterns vary by virus. Influenza A, for instance, tends to produce irregular areas of consolidation along the airways with widespread haziness, while RSV and rhinovirus create patchier, more scattered opacities. However, imaging alone can’t definitively identify the virus. Nasal swabs or blood tests are used to confirm which pathogen is responsible.
The Risk of Secondary Bacterial Infection
One of the more dangerous complications of viral pneumonia is a secondary bacterial infection, sometimes called a “superinfection.” The virus damages airway lining and disrupts the immune response, creating an opening for bacteria to take hold. In a large Ontario study of over 885,000 viral respiratory cases, influenza B had the highest rate of bacterial coinfection at 4.7%, followed by influenza A at 3.9% and RSV at 3.4%. COVID-19 had a lower overall coinfection rate of 0.3%, but among COVID patients who did develop bacterial infections, nearly 63% were secondary infections acquired during hospitalization, often from ventilators or IV lines.
A secondary bacterial infection can dramatically worsen the illness. If you seem to be improving from viral pneumonia and then suddenly spike a new fever or start coughing up discolored mucus, that’s a warning sign of bacterial superinfection that needs prompt medical attention.
Treatment Options
Most cases of viral pneumonia are treated with supportive care: rest, fluids, fever reducers, and cough management. Unlike bacterial pneumonia, antibiotics don’t work against viruses. For mild cases in otherwise healthy people, this is often enough, and recovery happens at home.
Antiviral medications are available for some viral causes. For COVID-19, options include an oral medication (Paxlovid) and an intravenous antiviral (remdesivir), both recommended for people at risk of severe illness. For influenza pneumonia, oseltamivir (Tamiflu) is the standard antiviral. Timing matters: antivirals work best when started within the first 5 to 7 days of symptom onset, and ideally much sooner.
For more severe cases, oxygen therapy is the cornerstone of hospital treatment. Doctors monitor blood oxygen levels with a pulse oximeter, and supplemental oxygen is given if levels drop too low. In the most serious cases, mechanical ventilation may be needed.
Recovery Timeline
Recovery from viral pneumonia varies widely. Some people feel better and return to normal routines within 1 to 2 weeks. For others, it takes a month or longer. Even after the infection clears, most people continue feeling tired for about a month. This lingering fatigue is normal and doesn’t necessarily mean something is wrong.
In rare severe cases, viral pneumonia can cause lasting lung damage. Necrotizing pneumonia, where infection kills patches of lung tissue and forms pus-filled abscesses, sometimes requires surgery or needle drainage. Some people, particularly those who had severe COVID-19 pneumonia, experience prolonged breathing difficulties or reduced exercise tolerance for months after the acute infection resolves.
Prevention Through Vaccination
Vaccines now exist for three of the most common viral causes of pneumonia. For the 2024-2025 season, the CDC recommends an updated COVID-19 vaccine for everyone 6 months and older, and an annual flu vaccine for the same age group.
RSV protection depends on your age. For infants, the CDC recommends either vaccinating the pregnant mother between weeks 32 and 36 of pregnancy or giving the baby a protective antibody (nirsevimab) at birth or just before RSV season. Children between 8 and 19 months at increased risk may also receive nirsevimab. For older adults, a single RSV vaccine dose is recommended for everyone 75 and older and for adults 60 to 74 who have risk factors for severe RSV disease.
Beyond vaccination, the same precautions that reduce spread of any respiratory virus apply: frequent handwashing, avoiding close contact with sick individuals, and staying home when you’re symptomatic to protect others, especially young children and older adults who are most vulnerable to severe disease.